GSK has dumped £978million of Haleon shares, cutting its stake in the world's largest standalone consumer healthcare firm to just 4.2%.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.